Topical clindamycin for acne vulgaris: analysis of gastrointestinal events

Article Properties
  • Language
    English
  • Publication Date
    2024/04/03
  • Indian UGC (journal)
  • Refrences
    51
  • Natalia M. Pelet del Toro Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA
  • Andrew Strunk Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA
  • Jashin J. Wu Department of Dermatology, University of Miami Miller School of Medicine, Miami, FL, USA
  • Linda Stein Gold Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA
  • James Q. Del Rosso JDR Dermatology Research/Thomas Dermatology, Las Vegas, NV, USAAdvanced Dermatology and Cosmetic Surgery, Maitland, FL, USADepartment of Dermatology, Touro University Nevada, Henderson, NV, USA
  • Robert T. Brodell Department of Dermatology, University of Mississippi Medical Center, Jackson, MS, USA
  • George Han Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA
Cite
Pelet del Toro, Natalia M., et al. “Topical Clindamycin for Acne Vulgaris: Analysis of Gastrointestinal Events”. Journal of Dermatological Treatment, vol. 35, no. 1, 2024, https://doi.org/10.1080/09546634.2024.2325603.
Pelet del Toro, N. M., Strunk, A., Wu, J. J., Stein Gold, L., Del Rosso, J. Q., Brodell, R. T., & Han, G. (2024). Topical clindamycin for acne vulgaris: analysis of gastrointestinal events. Journal of Dermatological Treatment, 35(1). https://doi.org/10.1080/09546634.2024.2325603
Pelet del Toro NM, Strunk A, Wu JJ, Stein Gold L, Del Rosso JQ, Brodell RT, et al. Topical clindamycin for acne vulgaris: analysis of gastrointestinal events. Journal of Dermatological Treatment. 2024;35(1).
Refrences
Title Journal Journal Categories Citations Publication Date
Big data and pharmacovigilance: data mining for adverse drug events and interactions 2018
Clindamycin phosphate 1.2%/tretinoin 0.025% gel for the treatment of acne vulgaris: which patients are most likely to benefit the most? 2015
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris 2014
Efficacy and safety of clindamycin phosphate 1.2% and tretinoin 0.025% gel for the treatment of acne and acne-induced post-inflammatory hyperpigmentation in patients with skin of color 2012
A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris 2010